Avirup Chakraborty, PhD

Special Interests

  • GBM
  • Tumor Microenvironment
  • Cancer Stem Cells
  • Immunotherapy
  • Tumor Metabolism


Dr. Chakraborty is a part of the brain cancer stem cell research group led by Dr. Deleyrolle and is an Assistant Scientist in the Department of Neurosurgery at the University of Florida. He received his BS and MS degrees from the University of Calcutta, Kolkata, India and completed his PhD from ICMR NICED, Kolkata, India and received his degree from University of Calcutta. Dr. Chakraborty’s doctoral research has been centered on examining the immune system’s alterations induced by Human Cytomegalovirus (HCMV) and its effects on the progression of HIV-1 in both children and adults. Additionally, he has investigated HCMV-related immune modifications leading to complexities and challenges following kidney transplants and autologous stem cell transplants.

Dr. Chakraborty also gathered post-doctoral experience in the fields of viral and cardiovascular immunity from University of Franche-Comte, Besancon, France and The Ohio State University, USA. In 2022, Dr. Chakraborty joined the Department of Neurosurgery at the University of Florida as a Postdoctoral Associate. His work focuses on: i) the metabolic diversity within brain tumors ii) developing and impact assessment of novel metabolic treatment approaches for brain cancer iii) the exploration of metabolic interactions within the tumor milieu, iv) the metabolic optimization of T cells to boost immunotherapy efficacy and v) the evaluation of the immunogenic potential of RNA from slow-cycling tumor cells for advancing cancer immunotherapies.